(Q52104784)

22 April 2018

title

Expression of human paraoxonase (PON1) during development. (English)

1 reference

22 April 2018

8

Aldons J Lusis

1 reference

22 April 2018

Toby B Cole

1

1 reference

22 April 2018

Rachel L Jampsa

2

1 reference

22 April 2018

Betsy J Walter

3

1 reference

22 April 2018

Tara L Arndt

4

1 reference

22 April 2018

Rebecca J Richter

5

1 reference

22 April 2018

Diana M Shih

6

1 reference

22 April 2018

Aaron Tward

7

1 reference

22 April 2018

Rhona M Jack

9

1 reference

22 April 2018

Lucio G Costa

10

1 reference

22 April 2018

Clement E Furlong

11

1 reference

22 April 2018

publication date

1 June 2003

1 reference

22 April 2018

Pharmacogenetics and Genomics

published in

1 reference

22 April 2018

volume

13

1 reference

22 April 2018

issue

6

1 reference

22 April 2018

page(s)

357-364

1 reference

22 April 2018

Decreased atherosclerotic lesion formation in human serum paraoxonase transgenic mice

cites work

1 reference

28 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/00008571-200306000-00007

Serum Paraoxonase Activity, Concentration, and Phenotype Distribution in Diabetes Mellitus and Its Relationship to Serum Lipids and Lipoproteins

1 reference

28 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/00008571-200306000-00007

Selective plasma hydrolysis of glucocorticoid gamma-lactones and cyclic carbonates by the enzyme paraoxonase: an ideal plasma inactivation mechanism

1 reference

28 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/00008571-200306000-00007

AGE VARIATION IN PLASMA ARYLESTERASE ACTIVITY IN CHILDREN

1 reference

28 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/00008571-200306000-00007

Serum paraoxonase status: a major factor in determining resistance to organophosphates.

1 reference

28 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/00008571-200306000-00007

The effect of the human serum paraoxonase polymorphism is reversed with diazoxon, soman and sarin

1 reference

28 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/00008571-200306000-00007

Paraoxonase prevents accumulation of lipoperoxides in low-density lipoprotein

1 reference

28 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/00008571-200306000-00007

Maturational differences in chlorpyrifos-oxonase activity may contribute to age-related sensitivity to chlorpyrifos.

1 reference

28 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/00008571-200306000-00007

Paraoxonase and atherosclerosis

1 reference

28 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/00008571-200306000-00007

Perinatal development of human blood esterases

1 reference

28 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/00008571-200306000-00007

Organophosphate detoxication potential of various rat tissues via A-esterase and aliesterase activities.

1 reference

28 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/00008571-200306000-00007

High expressor paraoxonase PON1 gene promoter polymorphisms are associated with reduced risk of vascular disease in younger coronary patients

1 reference

28 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/00008571-200306000-00007

Polymorphisms of paraoxonase genes and low-density lipoprotein lipid peroxidation

1 reference

28 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/00008571-200306000-00007

Human serum paraoxonase

1 reference

28 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/00008571-200306000-00007

Role of detoxication pathways in acute toxicity levels of phosphorothionate insecticides in the rat.

1 reference

28 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/00008571-200306000-00007

Paraoxonase protects against chlorpyrifos toxicity in mice

1 reference

28 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/00008571-200306000-00007

Paraoxonase polymorphism Met-Leu54 is associated with modified serum concentrations of the enzyme. A possible link between the paraoxonase gene and increased risk of cardiovascular disease in diabetes

1 reference

28 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/00008571-200306000-00007

Identification of residues essential for human paraoxonase (PON1) arylesterase/organophosphatase activities

1 reference

28 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/00008571-200306000-00007

The influence of age on the toxicity and metabolism of methyl parathion and parathion in male and female rats

1 reference

28 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/00008571-200306000-00007

Spectrophotometric assays for the enzymatic hydrolysis of the active metabolites of chlorpyrifos and parathion by plasma paraoxonase/arylesterase.

1 reference

28 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/00008571-200306000-00007

Catalytic efficiency determines the in-vivo efficacy of PON1 for detoxifying organophosphorus compounds.

1 reference

28 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/00008571-200306000-00007

Paraoxonase inhibits high-density lipoprotein oxidation and preserves its functions. A possible peroxidative role for paraoxonase

1 reference

28 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/00008571-200306000-00007

Human serum paraoxonases (PON1) Q and R selectively decrease lipid peroxides in human coronary and carotid atherosclerotic lesions: PON1 esterase and peroxidase-like activities

1 reference

28 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/00008571-200306000-00007

Paraoxonase (PON1) gene in mice: sequencing, chromosomal localization and developmental expression.

1 reference

28 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/00008571-200306000-00007

Effects of 5' regulatory-region polymorphisms on paraoxonase-gene (PON1) expression

1 reference

28 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/00008571-200306000-00007

The molecular basis of the human serum paraoxonase activity polymorphism.

1 reference

28 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/00008571-200306000-00007

Protective effect of high density lipoprotein associated paraoxonase. Inhibition of the biological activity of minimally oxidized low density lipoprotein

1 reference

28 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/00008571-200306000-00007

Paraoxonase (PON1) phenotype is a better predictor of vascular disease than is PON1(192) or PON1(55) genotype.

1 reference

28 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/00008571-200306000-00007

A polymorphism upstream from the human paraoxonase (PON1) gene and its association with PON1 expression

1 reference

28 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/00008571-200306000-00007

Characterization of cDNA clones encoding rabbit and human serum paraoxonase: the mature protein retains its signal sequence

1 reference

28 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/00008571-200306000-00007

Effect of the human serum paraoxonase 55 and 192 genetic polymorphisms on the protection by high density lipoprotein against low density lipoprotein oxidative modification

1 reference

28 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/00008571-200306000-00007

Promoter polymorphisms of human paraoxonase PON1 gene and serum paraoxonase activities and concentrations

1 reference

28 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/00008571-200306000-00007

Paraoxonase active site required for protection against LDL oxidation involves its free sulfhydryl group and is different from that required for its arylesterase/paraoxonase activities: selective action of human paraoxonase allozymes Q and R

1 reference

28 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/00008571-200306000-00007

Protection of low-density lipoprotein against oxidative modification by high-density lipoprotein associated paraoxonase

1 reference

28 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/00008571-200306000-00007

Alloenzymes of paraoxonase and effectiveness of high-density lipoproteins in protecting low-density lipoprotein against lipid peroxidation

1 reference

28 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/00008571-200306000-00007

Human and rabbit paraoxonases: purification, cloning, sequencing, mapping and role of polymorphism in organophosphate detoxification

1 reference

28 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/00008571-200306000-00007

Polymorphisms in the human paraoxonase (PON1) promoter

1 reference

28 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/00008571-200306000-00007

Absence of "A"-esterase activity in the serum of a patient with Tangier disease.

1 reference

28 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/00008571-200306000-00007

Cholinesterase, arylesterase, and lipoprotein parameters in twins

1 reference

28 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/00008571-200306000-00007

Mice lacking serum paraoxonase are susceptible to organophosphate toxicity and atherosclerosis

1 reference

28 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/00008571-200306000-00007

Analysis of paraoxonase (PON1) L55M status requires both genotype and phenotype

1 reference

28 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/00008571-200306000-00007

Serum paraoxonase (PON1) 55 and 192 polymorphism and paraoxonase activity and concentration in non-insulin dependent diabetes mellitus

1 reference

28 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/00008571-200306000-00007

Identifiers

DOI

10.1097/00008571-200306000-00007

1 reference

22 April 2018

1 reference

22 April 2018